Code available for discussion, page-35

I went to a Lifespot preso earlier in tbe year. Sounded promising but it was determined that it was to early for raising capital. They had to go back to the drawing board. Maybe its now further advanced.

Also it wasn't a proper diagnostic tool that the medical profession could rely on and thus did not require any FDA or eqivalent approvals.

There are plenty of skin cancer diagnostic apps being developed around the world. They take a photo of your suspect skin spot and determine if you have skin cancer or not.

Anyway I will be keen to look at it again when our mate Niv is ready.

Also, Neurotech is completely different and is way further down the track and has commercial contracts in place.

Also other stocks keep comparing themselves to RAP but its chalk and cheese. They will get found out quickly.

Cheers